a d GM-CSF for Melanoma | Oncolink - Cancer Resources

GM-CSF for Melanoma

Ultima Vez Modificado: 22 de marzo del 2010

Share article


Dear OncoLink "Ask The Experts,"
I was diagnosed with melanoma on my left foot, Stage Ib, in 2005. In 2009, I was found to have a recurrence in the left thigh. This was removed and there appears to be no organ involvement. I do not want to take any toxic treatments and am wondering about your thoughts on GM-CSF, which is my plan for treatment.

Thank you!


Keith T. Flaherty, MD, Assistant Professor of Medicine (Hematology/Oncology), responds:

GM-CSF as adjuvant therapy continues to be investigated in clinical trials, with no clear signal yet as to whether or not it helps to prevent recurrences of melanoma. It is clearly a well-tolerated therapy and therefore, has little going against it in that respect. There are ongoing trials testing the value of GM-CSF by itself, and others that are combining the therapy with other immunological therapies, such as vaccines. In conclusion, right now, the jury remains out on GM-CSF, and you should discuss the pros and cons of this therapy in your particular case with your oncologist(s).

I Wish You Knew

Skin cancer 101

View More

Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

OncoLink OncoPilot

Frente a un nuevo diagnóstico de cáncer o de cambiar el curso de su tratamiento actual? Deje que nuestro personal de enfermería cáncer que ayudan a pasar!

Más información